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Abstract: Thioacids derived from N-protected amino or dipeptide
and tripeptide acids undergo facile N-acylation with aromatic
amines to afford N-protected amino or peptide aryl amides in good
to excellent yields and enantiopurities. The method also furnishes
difficult-to-prepare N-Fmoc amino acid 4-nitroanilides in good
yields. This simple oxidative Nα-acylation of thioacids with aromat-
ic amines proceeds in the presence of iodine, 1-hydroxybenzotri-
azole and N,N-diisopropylethylamine at room temperature in
tetrahydrofuran.
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Amide bond formation is an important reaction in organic
synthesis as this moiety occurs widely in Nature.1 Hence,
there has been significant research on the development of
novel and efficient methods toward the formation of am-
ides.2 The most popular strategy for the generation of am-
ide bonds relies on the reactions of activated carboxylic
acids with amines.3 However, studies have also been di-
rected to the use of thioacids as efficient acylating agents.4
Thioacids have been used as precursors to thioesters,
which participate in ligation reactions in the chemical syn-
thesis of proteins.5,6 Due to the challenges in preparing
thioesters (especially in Fmoc chemistry),7 research has
focused on N-protected amino/peptide thioacids as alter-
natives to thioesters in native chemical ligation. This is
not only because of their easy preparation, but also on ac-
count of the numerous advantages over their carboxylic
acid (RCOOH) counterparts, such as solubility, acidity
and enhanced nucleophilicity.8 Thus, amino/peptide thio-
acids have been the subject of major endeavors devoted
toward the chemical assembly of polypeptides and a vari-
ety of proteins.9 Thioacids, similar to oxo-acids, do not
undergo acylation directly with amines; they need to be
activated prior to treatment with an amine. Importantly,
the activation of a thioacid is very mild and does not re-
quire any coupling reagent,10 and sometimes not even a
base.11 Such inherent advantages of thioacids have been
explored for the preparation of amides12 and peptidomi-
metics.13
Among pharmaceutical compounds possessing amide
bonds, aryl amides are an example of carboxamides,
which have generated significant interest in varied appli-
cations.14,15
Substituted aniline derivatives, in particular those pos-
sessing electron-withdrawing groups, do not undergo
straightforward condensation with carboxylic acids.
Therefore, a number of strategies have been developed for
the synthesis of C-terminal amino acid or peptide acid aryl
amides (Scheme 1). Aryl amides of tert-butoxycarbonyl
(Boc) or benzyloxycarbonyl (Cbz) amino acids are pre-
pared from carboxylic acids via the mixed anhydride
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method, or by using carbodiimides or other expensive
coupling reagents.16 Alternative procedures include the
Staudinger-type reaction in which azides are treated with
in situ generated N-protected amino acid selenocarboxyl-
ates.17 However, the preparation of selenocarboxylates is
cumbersome. Liskamp’s group have developed an elegant
protocol for the acylation of N-Cbz protected amino
acids/esters with amines mediated by Alcalase-CLEA en-
zyme.18 Although enantiomerically pure products were
obtained, the long reaction times and high temperature
were not suited to the general applicability of this proto-
col. Many aniline derivatives, being the amine compo-
nents for the preparation of the title compounds, have
basicities in the range of pH 8–9, and thus are not suitable
for 9-fluorenylmethoxycarbonyl (Fmoc) chemistry at
high temperature. Some attempts have been made to pre-
pare Fmoc-protected 4-nitroanilides,16f,g however, low
yields of products were obtained.
We report herein a rapid, high-yielding and racemization-
free synthesis of aryl amides via iodine-mediated oxida-
tive acylation of N-protected thioacids with substituted
anilines. The protocol is compatible with the three com-
monly employed peptide protecting groups (Fmoc, Boc
and Cbz), as well as several bifunctional amino acids,
peptides and a diverse range of substituted aniline deriva-
tives. In addition, N-protected amino acids such as serine,
threonine and tyrosine have been converted into the corre-
sponding aryl amides without protection of the hydroxyl
group. Iodine is a cheap and easily available reagent,
which has been used extensively in a number of reac-
tions.19 Danishefsky’s group have previously reported the
total chemical synthesis of complex glycoproteins via io-
dine-mediated oxidative acylation of amino and peptide
thioacids.9 In an earlier study, we prepared two dipep-
tides, Fmoc-(L)-Phg-Ala-OMe and Fmoc-(D)-Phg-Ala-
OMe, and studied their enantiopurities.20 These results es-
tablished that thioacids could be employed to acylate aryl
amines at room temperature in the presence of iodine and
1-hydroxybenzotriazole (HOBt) (Scheme 2). On the basis
of these studies, we initiated an investigation on the reac-
tion of N-protected thioacids with aniline derivatives.
The required N-protected amino and peptide thioacids 1
were prepared using our previously reported protocol.20
We have also reviewed the advantages of propanephos-
phonic acid anhydride (T3P®) over other traditional cou-
pling reagents in a variety of reactions.21 Hence, a
procedure involving T3P®-mediated activation of a car-
boxylic acid followed by treatment with sodium sulfide
(Na2S) was employed to prepare thioacids 1. Our study
began with the condensation of Fmoc-Ala-SH (1a, R1 =
Me) with aniline in the presence of iodine and HOBt at
room temperature in dimethyl sulfoxide (DMSO) as the
solvent (Table 1, entries 1 and 2). After five hours, the ex-
pected product 3a was isolated in a yield of 54–58%. Sol-
vents including acetonitrile, N,N-dimethylformamide,
dichloromethane and tetrahydrofuran were tested in this
reaction (Table 1, entries 3–7). Tetrahydrofuran was
found to be the best solvent, leading to the desired product
3a in 91% yield in 30 minutes. The use of N-methylmor-
pholine (NMM) as the tertiary base had no beneficial in-
fluence on the reaction rate, therefore we used N,N-
diisopropylethylamine (DIPEA) as the base (Table 1, en-
try 6). In order to ascertain the role of HOBt in the cou-
pling reaction, a control experiment was carried out in
which aniline was coupled to 1a in the absence of HOBt.
Under these conditions, the product yield was reduced
significantly to 58% (Table 2, entry 1), and the level of
epimerization increased to 12%. Thus, HOBt played a vi-
tal role in suppressing racemization as well as increasing
the yield. According to the mechanism established by
Danishefsky9 (Scheme 3), thioacylation can be achieved
in dimethyl sulfoxide, even in the absence of iodine. Con-
sequently, thioacid 1a was treated with aniline and HOBt
in dimethyl sulfoxide (Table 2, entry 2), however, it was
interesting to note that only 20% of the desired aryl amide
3a was detected after five hours. In contrast, thioacylation
of 1a with aniline mediated by iodine and HOBt in di-

















Table 1  Optimization of the Solvent for the Synthesis of 3aa
Entry Solvent Base Timeb Yield (%)c
1 DMSO DIPEA 5 h 54
2 DMSO NMM 5 h 58
3 MeCN DIPEA 4 h 61
4 DMF DIPEA 2 h 63
5 CH2Cl2 DIPEA 4 h 59
6 THF DIPEA 30 min 91
7 THF NMM 45 min 86
a Reactions were conducted at r.t.
b The reaction was monitored by TLC until thioacid 1a had been fully 
consumed.
c Yield of isolated product after column chromatography.
Table 2  Investigation of the Coupling of 1a with Anilinea
Entry Additive Solvent Yield (%)
1 none I2, DMSO 58
2 HOBt (2.0 equiv) DMSO 20
3 HOBt (2.0 equiv) I2, DMSO 54
4 HOBt (2.0 equiv) I2, THF 91
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methyl sulfoxide, led to an increase in the yield of 3a (Ta-
ble 2, entry 3). Although, dimethyl sulfoxide assists in the
formation of the intermediate diacyl disulfide, it is less ef-
ficient than tetrahydrofuran for formation of the O-benzo-
triazolyl (OBt) ester or amide product derived from the
diacyl disulfide.
To demonstrate the scope of the optimized protocol, a
series of N-protected thioacids was acylated with aniline
Table 3  Synthesis of N-Protected Aryl Amides 3
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derivatives containing electron-donating or electron-
withdrawing substituents. The results are summarized in
Table 3. It was found that the coupling of anilines with
electron-donating groups gave the corresponding prod-
ucts in higher yields than those possessing electron-with-
drawing groups. The aniline substrates containing ortho,
para, and meta substituents had no effect on the product
yield. Various Fmoc-, Boc- and Cbz-protected amino
thioacids were well-tolerated under the optimized reac-
tion conditions, leading to the desired aryl amides 3 in
good to excellent yields.
N-Protected amino acid 4-nitroanilides play a significant
role in biology and medicine.22 However, a number of the
reported methods for their synthesis result in low yields.
Despite the procedure employing phosphorus(V) oxy-
chloride (POCl3) giving 4-nitroanilides in almost 80%
yield,16g this reagent is not employed commonly as an ac-
ylating agent in peptide chemistry because of the inherent
disadvantages associated with sensitive protecting
groups. Thus, we focused our studies on the synthesis of
Fmoc-protected 4-nitroanilides 4a–f via the condensation
of Fmoc-protected amino thioacids with 4-nitroaniline.
The products were obtained in satisfactory yields after re-
crystallization from diethyl ether–THF (Table 4). Interest-
ingly, the reaction occurred efficiently with sterically
hindered amino thioacids such as Fmoc-Val, Fmoc-Pro
and Fmoc-Aib, affording the corresponding 4-nitroani-
lides in high purities (as confirmed by HPLC analysis).
Due to the wide functional group tolerance of the T3P®-
mediated thioacid preparation,20 we also addressed the
compatibility of the present protocol with unprotected bi-
functional amino acids. For this investigation, thioacids
derived from Fmoc-Ser, Fmoc-Thr, Fmoc-Tyr and Fmoc-
His were employed without protection of the side chain
functionalities. The aryl amides 5a–d derived from these
thioacids were obtained in good yields (Table 5).
In order to broaden the scope of the present methodology,
the synthesis of N-protected dipeptide and tripeptide acid
aryl amides was carried out (Scheme 4). The required
thioacids 6 were synthesized via T3P® activation of the re-
























Table 4  Synthesis of N-Protected 4-Nitroanilides 4
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spective oxo-acids. In general, the reactions of peptide
thioacids 6 with aniline derivatives were satisfactory,
however, the reaction times were longer, taking up to an
hour. In all cases, the peptidyl aryl amides 7 were isolated
in moderate to good yields (Table 6).
In conclusion, a general and efficient synthesis of enantio-
pure N-protected amino/peptide aryl amides has been de-
scribed. The coupling of N-protected amino, dipeptide
and tripeptide thioacids with aniline derivatives occurs in
the presence of iodine, HOBt and N,N-diisopropylethyl-
amine at room temperature in tetrahydrofuran. The scope
of this new protocol has been demonstrated using a vari-
ety of N-urethane protecting groups, and side-chain func-
tionalized and sterically hindered amino acids.
All solvents were freshly distilled before use. Amino acids were
used as received from Sigma-Aldrich. All the reactions were moni-
tored by TLC using Merck precoated silica gel plates. Column chro-
matography was performed with Merck silica gel (200–300 mesh)
at normal atmospheric pressure. Melting points were recorded on a
Kofler hot block in open capillary tubes and are uncorrected. IR
spectra were recorded on a Nicolet Impact 400D FT-IR spectropho-
tometer (KBr pellets, 3 cm–1 resolution). Optical rotation values
were recorded on a JASCO P-2000 digital polarimeter. 1H NMR
(400 MHz) and 13C NMR (75 MHz) were recorded on a Bruker
AMX 400 MHz instrument with tetramethylsilane (TMS) as the in-
ternal standard. HRMS analyses were recorded on a Q-Tof Micro-
mass spectrometer.
N-Protected Amino/Peptide Thioacids; General Procedure
To a soln of the appropriate carboxylic acid (1.0 mmol) and T3P®
(2.2 mmol) in anhyd MeCN (8.0 mL) was added Et3N (1.5 mmol)
at 0 °C, followed by finely ground Na2S (3.0 mmol). The resulting
mixture was stirred for 2–3 h until the reaction was complete (TLC
monitoring), concentrated and then diluted with H2O. The mixture
was acidified with aq citric acid soln (10%) and the product was ex-
tracted with EtOAc (10 mL). The organic layer was washed with
H2O (2 × 10 mL) and brine (10 mL), and then dried over anhyd
Na2SO4. The solvent was evaporated in vacuo to afford the corre-
sponding amino thioacid in quant. yield.
N-Protected Amino/Peptide Acid Aryl Amides; General Proce-
dure
To a stirred suspension of thioacid (1.0 mmol) in THF (5 mL) were
added I2 (0.6 mmol, 152 mg), DIPEA (1.2 mmol, 0.156 mL) and
HOBt (2.0 mmol, 270 mg) at r.t., followed by the appropriate amine
(1.1 mmol). The reaction mixture was stirred for 0.5 to 1 h as ana-
lyzed by TLC (until complete disappearance of the thioacid was ob-
served). After the reaction was complete, the solvent was
evaporated under vacuum and diluted with EtOAc (20 mL). The or-
ganic phase was washed with 10% HCl (2 × 10 mL), 1 N Na2CO3
(3 × 10 mL), H2O (2 × 10 mL) and brine (10 mL) and then dried
over anhydrous Na2SO4. The solvent was filtered and evaporated
under reduced pressure. The crude reaction mixture was purified
under column chromatography using hexane–EtOAc (7:3) as the el-
uent to afford the desired product. 
Fmoc-Ala-anilide (3a)
Yield: 0.355 g (91%); white solid; mp 191–193 °C; [α]D25 –27.5 (c
0.1, CHCl3).
IR (neat): 3359, 1689, 1528 cm–1.
Table 5  Synthesis of Unprotected Bifunctional Amino Acid Aryl Amides 5
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1H NMR (400 MHz, DMSO-d6): δ = 1.27 (d, J = 7.6 Hz, 3 H), 4.13–
4.24 (m, 4 H), 6.90 (d, J = 7.6 Hz, 2 H), 7.25–7.81 (m, 12 H), 9.94
(s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 16.4, 45.9, 51.3, 69.2, 122.3,
124.1, 127.1, 128.1, 128.6, 129.3, 139.1, 141.2, 143.7, 156.2, 172.1.
HRMS (ESI): m/z [M + Na]+ calcd for C24H22N2O3Na: 409.1528;
found: 409.1531.
Fmoc-Leu-3-methylanilide (3b)
Yield: 0.39 g (88%); white solid; mp 179 °C; [α]D25 –35.1 (c 0.1,
CHCl3).
IR (neat): 3288, 1686, 1530, 1258 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.97 (d, J = 7.8 Hz, 6 H), 1.87–
1.92 (m, 3 H), 2.34 (s, 3 H), 4.28–4.33 (m, 2 H), 4.61 (d, J = 7.2 Hz,
2 H), 6.89 (d, J = 5.8 Hz, 1 H), 7.19–7.80 (m, 12 H), 9.29 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 21.9, 24.2, 40.3, 48.1, 51.7,
67.8, 119.1, 121.7, 123.9, 125.4, 127.8, 128.1, 128.7, 137.3, 138.1,
139.8, 143.3, 156.2, 171.8.
HRMS (ESI): m/z [M + Na]+ calcd for C28H30N2O3Na: 465.2154;
found: 465.2151.
Fmoc-Lys(Boc)-4-methylanilide (3c)
Yield: 0.44 g (79%); white solid; mp 176–178 °C; [α]D25 –25.3
(c 0.1, CHCl3).
IR (neat): 3353, 1663, 1530, 1251 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.23–1.27 (m, 2 H), 1.39 (s, 9
H), 1.62–1.67 (m, 2 H), 1.92–1.96 (m, 2 H), 2.25 (s, 3 H), 2.81–2.85
(m, 2 H), 4.35–4.41 (m, 1 H), 4.42 (t, J = 5.6 Hz, 1 H), 4.64 (d,
J = 6.8 Hz, 2 H), 6.90 (br s, 2 H), 7.08–7.55 (m, 12 H), 8.91 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 21.9, 22.9, 24.1, 28.9, 30.0, 30.2,
32.2, 47.6, 55.9, 67.7, 117.5, 120.5, 121.1, 125.5, 125.8, 127.6,
128.2, 129.3, 139.4, 141.8, 144.2, 156.7, 156.9, 168.2, 170.5.
HRMS (ESI): m/z [M + Na]+ calcd for C33H39N3O5Na: 580.2787;
found: 580.2789.
Fmoc-Asp(t-Bu)-3-methylanilide (3d)
Yield: 0.4 g (81%); white solid; mp 132 °C; [α]D25 –38.5 (c 0.1,
CHCl3).
IR (neat): 3288, 1656, 1535, 1258 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.46 (s, 9 H), 2.33 (s, 3 H), 2.95–
3.00 (m, J = 3.6 Hz, 2 H), 4.20 (t, J = 6.8 Hz, 1 H), 4.46 (d, J = 6.8
Hz, 2 H), 4.58–4.65 (m, 1 H), 6.10 (br s, 1 H), 6.94 (d, J = 7.6 Hz,
1 H), 7.20–7.70 (m, 11 H), 8.48 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 22.0, 28.5, 38.0, 47.6, 52.2, 67.8,
82.7, 117.6, 120.6, 121.1, 125.5, 125.9, 127.6, 128.3, 129.3, 137.9,
139.4, 141.8, 144.1, 156.8, 169.0, 171.8.
HRMS (ESI): m/z [M + Na]+ calcd for C30H32N2O5Na: 523.2209;
found: 523.2212.
Table 6  Synthesis of N-Protected Peptide Aryl Amides 7
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Fmoc-Phg-3-methylanilide (3e)
Yield: 0.4 g (86%); white solid; mp 218 °C; [α]D25 –32.1 (c 0.1,
CHCl3).
IR (neat): 3277, 1656, 1535, 1258 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 2.25 (s, 3 H), 4.22–4.28 (m, 3
H), 5.43 (d, J = 8.0 Hz, 1 H), 6.80 (d, J = 7.2 Hz, 1 H), 7.15–8.20
(m, 17 H), 10.24 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 24.2, 46.3, 66.1, 119.3, 120.9,
125.1, 126.3, 127.4, 128.3, 128.8, 129.1, 129.6, 138.3, 138.7, 156.2,
169.2.
HRMS (ESI): m/z [M + H]+ calcd for C30H27N2O3: 463.2022; found:
463.2019.
Fmoc-Met-2-chloroanilide (3f)
Yield: 0.41 g (85%); white solid; mp 187–188 °C; [α]D25 –29.2
(c 0.1, CHCl3).
IR (neat): 3295, 1678, 1532, 1256 cm–1.
1H NMR (400 MHz, CDCl3): δ = 2.13 (s, 3 H), 2.65–2.61 (m, 2 H),
2.74 (t, J = 6.0 Hz, 2 H), 4.24 (t, J = 6.4 Hz, 1 H), 4.45–4.46 (m, 3
H), 5.60 (d, J = 8.0 Hz, 1 H), 6.10 (br s, 1 H), 7.05–7.70 (m, 11 H),
8.80 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 16.9, 28.7, 32.3, 45.4, 55.1, 69.1,
123.8, 126.1, 126.8, 127.3, 128.4, 128.7, 129.6, 131.5, 137.3, 140.9,
144.7, 155.9, 169.7.
HRMS (ESI): m/z [M + Na]+ calcd for C26H25ClN2O3SNa:
503.1172; found: 503.1171.
Fmoc-Pro-3-chloroanilide (3g)
Yield: 0.34 g (77%); white solid; mp 180–184 °C; [α]D25 –26.4
(c 0.1, CHCl3).
IR (neat): 3332, 1672, 1545, 1421 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.82–1.87 (m, 2 H), 2.01–2.07 (m,
2 H), 3.14 (t, J = 4.8 Hz, 2 H), 4.10 (t, J = 5.4 Hz, 1 H), 4.35 (t,
J = 5.0 Hz, 1 H), 4.89 (d, J = 7.4 Hz, 2 H), 6.93 (d, J = 7.2 Hz, 1 H),
7.23–7.56 (m, 11 H), 8.92 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 25.2, 28.5, 47.6, 48.1, 61.5, 68.5,
118.1, 120.2, 120.5, 124.4, 125.4, 127.5, 127.6, 128.3, 130.2, 134.9,
139.7, 141.8, 144.1, 157.3, 170.0.
HRMS (ESI): m/z [M + Na]+ calcd for C26H23ClN2O3Na: 469.1295;
found: 469.1291.
Fmoc-Ser-3-methylanilide (3h)
Yield: 0.36 g (87%); white solid; mp 190–192 °C; [α]D25 –21.5
(c 0.1, CHCl3).
IR (neat): 3272, 1654, 1535, 1257 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 2.27 (s, 3 H), 3.64 (d, J = 6.0
Hz, 2 H), 4.21–4.30 (m, 4 H), 6.86 (d, J = 6.8 Hz, 1 H), 7.10–7.90
(m, 11 H), 8.10 (s, 1 H), 9.90 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 21.7, 47.1, 62.2, 116.9, 120.2,
120.6, 124.4, 125.8, 127.6, 128.1, 129.0, 138.3, 139.4, 141.2, 144.3,
144.4, 156.4, 172.6.
HRMS (ESI): m/z [M + Na]+ calcd for C25H24N2O4Na: 439.1634;
found: 439.1634.
Fmoc-Val-4-morpholino-anilide (3i)
Yield: 0.42 g (83%); white solid; mp 213–215 °C; [α]D25 –32.1
(c 0.1, CHCl3).
IR (neat): 3287, 1682, 1537, 1254 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.97 (d, J = 7.4 Hz, 6 H), 2.51–
2.58 (m, 1 H), 3.20 (t, J = 4.6 Hz, 4 H), 3.71 (t, J = 4.6 Hz, 4 H),
4.32 (t, J = 5.2 Hz, 1 H), 4.57 (d, J = 6.4 Hz, 2 H), 4.72–4.85 (m, 1
H), 6.57 (d, J = 7.2 Hz, 2 H), 6.80 (br s, 1 H), 7.28–7.78 (m, 10 H),
10.21 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 17.4, 28.9, 44.7, 46.8, 57.4,
63.2, 68.1, 114.7, 121.3, 125.8, 127.3, 128.4, 128.7, 129.4, 140.1,
142.7, 144.4, 156.2, 170.7.
HRMS (ESI): m/z [M + Na]+ calcd for C30H33N3O4Na: 522.2369;
found: 522.2364.
Fmoc-Ala-4-pyrazolo-anilide (3j)
Yield: 0.34 g (76%); white solid; mp 227–229 °C; [α]D25 –37.1
(c 0.1, CHCl3).
IR (neat): 3293, 1725, 1668, 1533 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.32 (d, J = 6.4 Hz, 3 H), 2.80–
2.86 (m, 1 H), 4.24 (t, J = 4.8 Hz, 1 H), 4.47 (d, J = 7.2 Hz, 2 H),
5.90 (br s, 1 H), 6.34 (d, J = 6.8 Hz, 1 H), 7.23–7.80 (m, 14 H), 8.92
(s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 16.5, 46.3, 66.9, 109.1, 121.3,
122.7, 125.9, 126.2, 127.8, 128.4, 133.4, 136.7, 140.4, 143.2, 156.6,
171.8.
HRMS (ESI): m/z [M + Na]+ calcd for C27H24N4O3Na: 475.1746;
found: 475.1748.
Cbz-Phe-3,4-difluoroanilide (3k)16i
Yield: 0.26 g (65%); white solid; mp 162–164 °C; [α]D25 –25.6
(c 0.1, CHCl3).
IR (neat): 3284, 1653, 1530, 1283 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 2.88 (d, J = 6.8 Hz, 2 H), 4.29
(t, J = 5.2 Hz, 1 H), 5.14 (s, 2 H), 6.92 (d, J = 7.2 Hz, 1 H), 7.20–
7.38 (m, 11 H), 7.60–7.80 (m, 2 H), 10.25 (br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 36.3, 55.1, 66.0, 110.4, 116.5,
118.2, 125.8, 126.7, 127.3, 128.1, 128.5, 129.4, 136.3, 138.8, 140.2,
146.2, 148.4, 156.7, 172.0.
HRMS (ESI): m/z [M + Na]+ calcd for C23H20F2N2O3Na: 433.1340;
found: 433.1337.
Cbz-Leu-4-pyrrolylanilide (3l)16i
Yield: 0.33 g (81%); white solid; mp 219–221 °C; [α]D25 –27.1
(c 0.1, CHCl3).
IR (neat): 3284, 1685, 1594, 1531 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.84 (d, J = 7.2 Hz, 6 H), 1.14–
1.19 (m, 1 H), 1.44–1.52 (m, 2 H), 4.00 (t, J = 4.2 Hz, 1 H), 5.01 (s,
2 H), 5.58 (br s, 1 H), 6.22 (d, J = 6.4 Hz, 2 H), 7.12–7.65 (m, 11
H), 10.06 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 21.8, 22.3, 41.7, 50.3, 66.1,
110.3, 121.5, 122.2, 123.9, 127.0, 127.8, 129.4, 135.3, 137.1, 140.9,
156.2, 171.8.
HRMS (ESI): m/z [M + Na]+ calcd for C24H27N3O3Na: 428.1950;
found: 428.1952.
Cbz-Phe-4-cyanoanilide (3m)18
Yield: 0.31 g (78%); white solid; mp 170 °C; [α]D25 –35.7 (c 0.1,
CHCl3).
IR (neat): 3325, 2235, 1530, 1251 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 2.87 (d, J = 7.2 Hz, 2 H), 3.05
(t, J = 4.4 Hz, 1 H), 4.97 (s, 2 H), 7.14–7.56 (m, 12 H), 7.79 (d,
J = 6.6 Hz, 2 H), 8.09 (br s, 1 H), 10.46 (br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 37.2, 56.9, 65.3, 111.4, 118.5,
121.9, 123.8, 126.3, 126.9, 127.4, 127.6, 128.0, 128.2, 129.1, 130.1,
136.8, 137.5, 139.4, 155.9, 171.1.
HRMS (ESI): m/z [M + Na]+ calcd for C24H21N3O3Na: 422.1481;
found: 422.1483.
Boc-Val-3-bromoanilide (3n)
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IR (neat): 3314, 1683, 1532, 1249 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.03 (d, J = 7.2 Hz, 6 H), 1.37
(s, 9 H), 2.66–2.78 (m, 1 H), 4.04–4.07 (m, 1 H), 7.13–7.52 (m, 4
H), 7.92 (br s, 1 H), 9.80 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 17.8, 27.9, 32.4, 58.2, 78.5,
120.4, 120.9, 123.4, 127.1, 130.7, 139.2, 155.8, 172.3.
HRMS (ESI): m/z [M + Na]+ calcd for C16H23BrN2O3Na: 393.0790;
found: 393.0785.
Fmoc-Ala-4-nitroanilide (4a)16f 
Yield: 0.35 g (81%); white solid; mp 181–183 °C; [α]D25 –30.5
(c 0.1, CHCl3).
IR (neat): 2983, 1737, 1372, 1234 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.31 (d, J = 4.2 Hz, 3 H), 4.11
(t, J = 6.0 Hz, 1 H), 4.43 (d, J = 5.6 Hz, 2 H), 4.65–4.70 (m, 1 H),
5.11 (br s, 1 H), 7.11–8.12 (m, 12 H), 10.80 (br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 16.5, 45.5, 49.6, 66.3, 120.4,
121.6, 125.8, 126.4, 127.1, 127.8, 140.1, 141.2, 143.2, 143.8, 155.8,
171.2.
HRMS (ESI): m/z [M + Na]+ calcd for C24H21N3O5Na: 454.1379;
found: 454.1368.
Fmoc-Val-4-nitroanilide (4b)16g
Yield: 0.34 g (75%); white solid; mp 185–187 °C; [α]D25 –39.1
(c 0.1, CHCl3).
IR (neat): 3329, 1685, 1533, 1383 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.96 (d, J = 7.2 Hz, 6 H), 2.45–
2.53 (m, 1 H), 4.21–4.28 (m, 2 H), 4.51 (d, J = 5.8 Hz, 2 H), 5.29
(br s, 1 H), 7.18–8.15 (m, 12 H), 9.80 (br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 16.8, 30.5, 45.7, 58.5, 67.6,
121.2, 121.6, 125.5, 126.8, 127.4, 127.8, 140.0, 141.5, 143.3, 143.9,
155.0, 171.1.
HRMS (ESI): m/z [M + Na]+ calcd for C26H25N3O5Na: 482.1692;
found: 482.1680.
Fmoc-Leu-4-nitroanilide (4c)16f
Yield: 0.38 g (80%); white solid; mp 190 °C; [α]D25 –36.4 (c 0.1,
CHCl3).
IR (neat): 3299, 1635, 1538, 1372 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.98 (d, J = 8.4 Hz, 6 H), 1.75–
1.81 (m, 3 H), 4.22–4.31 (m, 2 H), 4.61 (d, J = 5.8 Hz, 2 H), 5.55
(br s, 1 H), 7.11–8.21 (m, 12 H), 10.60 (br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 21.8, 22.0, 40.2, 46.5, 50.8,
66.8, 120.8, 121.5, 126.4, 126.8, 127.0, 128.0, 139.7, 141.0, 142.8,
143.4, 155.0, 170.7.
HRMS (ESI): m/z [M + Na]+ calcd for C27H27N3O5Na: 496.1848;
found: 496.1831.
Fmoc-Pro-4-nitroanilide (4d)16f
Yield: 0.32 g (69%); white solid; mp 183–184 °C; [α]D25 –53.4
(c 0.1, CHCl3).
IR (neat): 3315, 1658, 1543, 1425 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.22–1.27 (m, 2 H), 1.85–1.94
(m, 2 H), 3.21–3.26 (m, 2 H), 4.12–4.18 (m, 1 H), 4.28 (t, J = 7.2
Hz, 1 H), 4.57 (d, J = 6.8 Hz, 2 H), 7.10–8.12 (m, 12 H), 9.60 (br s,
1 H).
13C NMR (75 MHz, DMSO-d6): δ = 21.8, 28.5, 46.8, 47.0, 61.5,
67.0, 121.5, 121.9, 127.2, 127.8, 128.0, 128.2, 139.9, 141.5, 143.1,
143.5, 155.2, 170.8.
HRMS (ESI): m/z [M + Na]+ calcd for C26H23N3O5Na: 480.1535;
found: 480.1530.
Fmoc-Aib-4-nitroanilide (4e)
Yield: 0.28 g (63%); white solid; mp 197–199 °C.
IR (neat): 3318, 1669, 1539, 1382 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.41 (s, 6 H), 4.30 (t, J = 4.2
Hz, 1 H), 4.55 (d, J = 4.9 Hz, 2 H), 5.11 (br s, 1 H), 7.11–8.15 (m,
12 H), 10.23 (br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 24.7, 45.8, 47.1, 66.8, 121.2,
121.7, 126.4, 127.8, 128.0, 128.2, 139.5, 141.0, 143.6, 143.8, 155.1,
171.2.
HRMS (ESI): m/z [M + Na]+ calcd for C25H23N3O5Na: 468.1535;
found: 468.1522.
Boc-Phe-4-nitroanilide (4f)16g
Yield: 0.3 g (78%); white solid; mp 172–173 °C; [α]D25 –42.6 (c 0.1,
CHCl3).
IR (neat): 3289, 1663, 1534, 1381 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.32 (s, 9 H), 2.85–2.91 (m, 2
H), 4.77–4.85 (m, 1 H), 5.08 (br s, 1 H), 7.01–8.05 (m, 9 H), 9.80
(br s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 27.5, 37.2, 54.1, 79.2, 121.1,
121.8, 125.7, 127.2, 128.1, 139.1, 144.0, 144.1, 155.7, 172.1.
HRMS (ESI): m/z [M + Na]+ calcd for C20H23N3O5Na: 408.1535;
found: 408.1519.
Fmoc-Ser-4-cyanoanilide (5a)
Yield: 0.34 g (79%); white solid; mp 173–175 °C; [α]D25 –34.5
(c 0.1, CHCl3).
IR (neat): 3312, 2225, 1672, 1542 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 3.80 (d, J = 5.6 Hz, 2 H), 4.24
(t, J = 8.0 Hz, 1 H), 4.48 (d, J = 6.4 Hz, 2 H), 4.68–4.75 (m, 1 H),
6.20 (br s, 1 H), 7.20–7.80 (m, 12 H), 9.80 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 45.3, 53.1, 60.8, 67.2, 108.9,
113.7, 121.8, 125.3, 127.4, 128.0, 128.6, 131.5, 140.2, 141.8, 143.2,
156.4, 172.8.
HRMS (ESI): m/z [M + Na]+ calcd for C25H21N3O4Na: 450.1430;
found: 450.1427.
Fmoc-Thr-2-methylanilide (5b)
Yield: 0.35 g (82%); white solid; mp 190 °C; [α]D25 –35.7 (c 0.1,
CHCl3).
IR (neat): 3285, 1654, 1535, 1235 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.30 (d, J = 6.4 Hz, 3 H), 2.31
(s, 3 H), 3.91–4.01 (m, 1 H), 4.37 (t, J = 4.8 Hz, 1 H), 4.64–4.71 (m,
3 H), 5.86 (br s, 1 H), 6.87–7.03 (m, 3 H), 7.23–7.50 (m, 9 H), 9.95
(s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 14.7, 18.2, 46.9, 59.4, 66.9,
68.1, 121.8, 123.7, 125.9, 126.3, 127.8, 128.1, 128.5, 129.7, 133.8,
137.2, 140.3, 143.5, 155.8, 171.3.
HRMS (ESI): m/z [M + Na]+ calcd for C26H26N2O4Na: 453.1790;
found: 453.1735.
Fmoc-Tyr-2-chloroanilide (5c)
Yield: 0.45 g (88%); white solid; mp 194–196 °C; [α]D25 –43.2
(c 0.1, CHCl3).
IR (neat): 3159, 1657, 1538, 1446 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 3.10–3.18 (m, 2 H), 4.41 (t,
J = 5.2 Hz, 1 H), 4.63 (d, J = 6.2 Hz, 2 H), 4.78–4.85 (m, 1 H), 5.63
(br s, 1 H), 6.62 (s, 2 H), 6.85 (s, 2 H), 7.15–7.55 (m, 12 H), 10.25
(s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 36.3, 47.1, 53.8, 67.9, 114.3,
122.7, 125.1, 125.5, 126.5, 126.9, 127.8, 128.3, 128.9, 129.4, 130.2,
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HRMS (ESI): m/z [M + Na]+ calcd for C30H25ClN2O4Na: 535.1401;
found: 535.1408.
Fmoc-His-4-nitroanilide (5d)
Yield: 0.37 g (75%); white solid; mp 225–228 °C; [α]D25 –38.5
(c 0.1, CHCl3).
IR (neat): 3105, 2856, 1854, 1628 cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.51 (d, J = 6.4 Hz, 2 H), 4.47 (t,
J = 5.4 Hz, 1 H), 4.63 (d, J = 7.2 Hz, 2 H), 4.80 (t, J = 6.2 Hz, 1 H),
6.30 (br s, 1 H), 6.75 (s, 1 H), 7.28–7.87 (m, 11 H), 8.15 (d, J = 6.8
Hz, 2 H), 9.70 (s, 1 H), 12.30 (br s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 28.7, 46.4, 51.7, 66.9, 118.5,
120.9, 122.2, 126.7, 127.8, 128.6, 133.8, 135.1, 141.2, 143.0, 144.1,
144.8, 156.5, 172.1.
HRMS (ESI): m/z [M + Na]+ calcd for C27H23N5O5Na: 520.1597;
found: 520.1591.
Fmoc-Gly-Phe-3-methylanilide (7a)
Yield: 0.44 g (83%); white solid; mp 235–237 °C; [α]D25 –93.6
(c 0.1, CHCl3).
IR (neat): 3314, 2922, 1640, 1536 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 2.31 (s, 3 H), 3.05–3.16 (m, 2
H), 3.72 (s, 2 H), 4.32 (t, J = 5.4 Hz, 1 H), 4.42–4.61 (m, 3 H), 6.78
(d, J = 6.4 Hz, 1 H), 7.15–7.79 (m, 18 H), 9.10 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 24.1, 35.3, 41.7, 46.9, 53.4,
67.4, 119.4, 121.3, 123.4, 126.1, 126.5, 127.1, 127.8, 128.3, 128.7,
129.1, 137.9, 138.3, 139.8, 140.7, 143.2, 156.4, 169.6, 172.8.
HRMS (ESI): m/z [M + Na]+ calcd for C33H31N3O4Na: 556.2212;
found: 556.2222.
Fmoc-Val-Ala-4-chloroanilide (7b)
Yield: 0.45 g (86%); white solid; mp 243 °C; [α]D25 +79.3 (c 0.1,
CHCl3).
IR (neat): 3298, 2955, 1675, 1535 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.07 (d, J = 7.2 Hz, 6 H), 1.32
(d, J = 6.6 Hz, 3 H), 2.48–2.56 (m, 1 H), 4.43–4.50 (m, 2 H), 4.63
(d, J = 6.8 Hz, 2 H), 4.78–4.85 (m, 1 H), 6.80 (br s, 1 H), 7.25–7.90
(m, 13 H), 9.72 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 16.8, 17.4, 30.2, 46.8, 48.2,
58.7, 67.2, 123.7, 126.4, 127.8, 128.0, 128.3, 128.7, 129.4, 137.6,
139.5, 143.1, 156.5, 170.3, 171.7.
HRMS (ESI): m/z [M + Na]+ calcd for C29H30ClN3O4Na: 542.1823;
found: 542.1825.
Fmoc-Ala-Leu-4-methoxyanilide (7c)
Yield: 0.42 g (79%); white solid; mp 253–255 °C; [α]D25 +18.3
(c 0.1, CHCl3).
IR (neat): 3307, 2825, 1682, 1538 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.95 (d, J = 7.2 Hz, 6 H), 1.39
(d, J = 6.2 Hz, 3 H), 1.81–1.87 (m, 3 H), 3.68 (s, 3 H), 4.42–4.53
(m, 3 H), 4.63 (d, J = 6.8 Hz, 2 H), 6.71 (d, J = 7.0 Hz, 2 H), 7.25–
7.51 (m, 12 H), 8.95 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 17.5, 21.3, 22.4, 40.9, 48.4,
50.3, 50.8, 56.2, 68.1, 114.6, 122.3, 126.0, 127.6, 128.2, 131.4,
141.2, 143.1, 156.3, 156.7, 170.5, 172.4.
HRMS (ESI): m/z [M + Na]+ calcd for C31H35N3O5Na: 552.2474;
found: 552.2471.
Cbz-Phe-Leu-2-chloroanilide (7d)
Yield: 0.42 g (81%); white solid; mp 231–232 °C; [α]D25 –123.5
(c 0.1, CHCl3).
IR (neat): 3283, 2846, 1698, 1535 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.10 (d, J = 7.4 Hz, 6 H), 1.80–
1.83 (m, 2 H), 2.85 (d, J = 6.6 Hz, 2 H), 4.35–4.42 (m, 3 H), 5.27 (s,
2 H), 5.80 (br s, 1 H), 6.90–7.21 (m, 14 H), 7.42 (br s, 1 H), 9.72 (s,
1 H).
13C NMR (75 MHz, DMSO-d6): δ = 16.1, 21.3, 22.7, 36.8, 42.5,
50.4, 53.7, 123.7, 125.4, 125.9, 126.8, 127.1, 127.5, 127.9, 128.3,
128.8, 129.3, 131.2, 135.3, 139.1, 141.7, 156.3, 169.8, 171.4.
HRMS (ESI): m/z [M + Na]+ calcd for C29H32ClN3O4Na: 544.1979;
found: 544.1975.
Boc-Ala-Ile-4-methylanilide (7e)
Yield: 0.3 g (76%); white solid; mp 218–221 °C; [α]D25 –58.5 (c 0.1,
CHCl3).
IR (neat): 3292, 2916, 1613, 1529 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.85 (t, J = 5.2 Hz, 3 H), 1.00
(d, J = 6.8 Hz, 3 H), 1.18–1.21 (m, 2 H), 1.37 (s, 9 H), 1.45 (d,
J = 7.4 Hz, 3 H), 2.25–2.34 (m, 1 H), 2.36 (s, 3 H), 4.40 (d, J = 6.2
Hz, 1 H), 5.61 (br s, 1 H), 6.80 (br s, 1 H), 7.15 (d, J = 5.6 Hz, 2 H),
7.62 (d, J = 5.6 Hz, 2 H), 8.63 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 13.1, 15.2, 18.4, 23.5, 24.6,
28.1, 35.4, 49.7, 54.1, 78.5, 120.8, 129.1, 133.5, 135.1, 156.7,
170.1, 172.3
HRMS (ESI): m/z [M + Na]+ calcd for C21H33N3O4Na: 414.2369;
found: 414.2372.
Boc-Gly-Val-4-pyrrolylanilide (7f)
Yield: 0.33 g (80%); white solid; mp 227–279 °C; [α]D25 –29.7
(c 0.1, CHCl3).
IR (neat): 3297, 2928, 1625, 1532 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.13 (d, J = 7.2 Hz, 6 H), 1.35
(s, 9 H), 2.31–2.37 (m, 1 H), 3.73 (d, J = 6.6 Hz, 2 H), 4.41 (d,
J = 7.0 Hz, 1 H), 5.57 (br s, 1 H), 6.13 (d, J = 5.8 Hz, 2 H), 6.83 (d,
J = 5.8 Hz, 2 H), 7.21 (d, J = 6.2 Hz, 2 H), 7.65 (d, J = 6.2 Hz, 2 H),
7.80 (br s, 1 H), 9.85 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 17.8, 27.3, 31.5, 46.1, 55.7,
78.9, 109.2, 121.7, 122.5, 124.1, 134.6, 135.4, 156.1, 170.3, 171.5.
HRMS (ESI): m/z [M + Na]+ calcd for C22H30N4O4Na: 437.2165;
found: 437.2158.
Cbz-Phe-Ile-Ala-4-chloroanilide (7g)
Yield: 0.45 g (75%); white solid; mp 235 °C; [α]D25 +23.4 (c 0.1,
CHCl3).
IR (neat): 3311, 2954, 2925, 1631 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 1.03 (t, J = 7.2 Hz, 3 H), 1.15
(d, J = 6.6 Hz, 3 H), 1.32–1.40 (m, 2 H), 1.53 (d, J = 7.0 Hz, 3 H),
2.25–2.34 (m, 1 H), 2.85 (d, J = 5.8 Hz, 2 H), 3.84 (d, J = 5.4 Hz, 1
H), 4.45–4.53 (m, 1 H), 4.72–4.81 (m, 1 H), 5.21 (s, 2 H), 5.80 (br
s, 1 H), 6.64 (br s, 1 H), 7.18–7.52 (m, 14 H), 9.85 (s, 1 H).
13C NMR (75 MHz, DMSO-d6): δ = 11.3, 15.1, 17.6, 26.1, 38.1,
38.6, 45.4, 53.1, 55.8, 64.3, 122.6, 125.4, 126.8, 127.4, 128.8,
129.5, 129.7, 134.5, 138.3, 140.2, 155.3, 168.8, 170.5, 142.3.
HRMS (ESI): m/z [M + Na]+ calcd for C32H37ClN4O5Na: 615.2350;
found: 615.2348.
Boc-Gly-Ala-Ile-anilide (7h)
Yield: 0.33 g (76%); white solid; mp 241–243 °C; [α]D25 +68.3
(c 0.1, CHCl3).
IR (neat): 3295, 2961, 2884, 1626 cm–1.
1H NMR (400 MHz, DMSO-d6): δ = 0.87 (t, J = 4.8 Hz, 3 H), 1.09
(d, J = 6.4 Hz, 3 H), 1.20–1.27 (m, 2 H), 1.34 (s, 9 H), 1.48 (d,
J = 6.8 Hz, 3 H), 2.80–2.89 (m, 1 H), 3.51 (s, 2 H), 4.43 (d, J = 7.6
Hz, 1 H), 4.78–4.85 (m, 1 H), 5.23 (br s, 1 H), 6.82 (br s, 1 H), 7.10–
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13C NMR (75 MHz, DMSO-d6): δ = 12.1, 14.3, 16.8, 26.2, 28.4,
38.2, 43.2, 47.8, 56.5, 79.7, 120.6, 123.9, 129.4, 136.3, 155.72,
169.4, 171.5.
HRMS (ESI): m/z [M + Na]+ calcd for C22H34N4O5Na: 457.2427;
found: 457.2454.
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